Clinical Trials Sponsored by Oncoceutics, Inc.

Total 35632 results

Mylan Pharmaceuticals Inc

Completed

Fasting Study of Finasteride Tablets 5 mg and Proscar Tablets 5 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Tablets 20 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg and Lopressor HCT® Tablets 100/50 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study Metformin Hydrochloride ER Tablets 750 mg and Glucophage XR 750 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Fluoxetine Capsules 40 mg and Prozac Pulvules 40 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg to Lopressor HCT® Tablets 100/50 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Cilostazol Tablets 100 mg and Pletal® Tablets 100 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Finasteride Tablets 5 mg and Proscar® Tablets 5 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Terminated

Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Terminated

Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Metoprolol Tartrate Tablets 100 mg and Lopressor® 100 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® 250 mg

Healthy

United States
Edgewise Therapeutics, Inc.
Medpace, Inc.

Completed

A Study of EDG-5506 in Adult Males With Becker Muscular Dystrophy (ARCH)

Becker Muscular Dystrophy

United States
Orlando Health, Inc.
ChiRhoClin, Inc.

Terminated

Recurrent Abdominal Pain and Exocrine Pancreatic Insufficiency

Irritable Bowel Syndrome | Abdominal Pain

United States
Eisai Korea Inc.

Completed

A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients

Carcinoma | Renal Cell Carcinoma | Endometrial Neoplasms | Endometrium

Korea, Republic of
Spino Modulation Inc.

Terminated

Fusionless Treatment of Idiopathic Scoliosis With the SCOLI-TETHER System During The Growth Period (FUTURE)

Adolescent Idiopathic Scoliosis | Juvenile Idiopathic Scoliosis

Canada
Stuart Therapeutics, Inc.
ORA, Inc.

Completed

Study of ST-100 as Treatment for Dry Eye Disease

Dry Eye Disease

United States
Tonix Pharmaceuticals, Inc.
Rho, Inc.

Completed

Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD) (UPLIFT)

Depressive Disorder | Depression | Depressive Symptoms | Depressive Disorder, Major | Depressive Episode | Depression Severe

United States
Pacira Pharmaceuticals, Inc
Medpace, Inc.

Terminated

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis

Adhesive Capsulitis | Osteoarthritis of the Shoulder

United States
GB004, Inc.

Terminated

A Study With GB004 in Adult Subjects With Active Ulcerative Colitis (UC)

Ulcerative Colitis

United States, Korea, Republic of, Serbia, Ukraine, Romania, Georgia, Russian Federation, Moldova, Republic of, Poland
Novan, Inc.
Chiltern International Inc.

Completed

P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne

Acne Vulgaris

United States
Eisai Inc.
PharmaBio Development Inc.

Terminated

Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer

Rectal Cancer | Colon Cancer

Argentina, Russian Federation, United States, Australia, Brazil, Ukraine
Milestone Pharmaceuticals Inc.
Medpace, Inc.

Terminated

Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302

Paroxysmal Supraventricular Tachycardia

United States, Canada
Synchron Medical, Inc.

Withdrawn

SWITCH II Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis

Paralysis | Amyotrophic Lateral Sclerosis | Muscular Dystrophies | Neurologic Disorder | Spinal Muscular Atrophy | Spinal Cord Injury | Stroke, Lacunar | Upper Limb Injury | Paralysis; Stroke | Stroke, Brainstem

Australia
Vivozon Pharmaceutical Inc.

Completed

Phase 3 Efficacy and Safety of VVZ-149 Injections for Postoperative Pain Following Laparoscopic Colectomy

Pain, Postoperative | Acute Pain

Korea, Republic of
Eisai Korea Inc.

Completed

A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) Participants

Carcinoma, Hepatocellular | Liver Neoplasms

Korea, Republic of
Ceragem Clinical Inc.

Completed

CEFID-I (CEra Flow Improves DVT-1)

Deep Vein Thrombosis | Blood Circulation Disorder

Korea, Republic of
LENZ Therapeutics, Inc
ORA, Inc.

Completed

Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia

Eye Diseases | Refractive Errors | Presbyopia

United States
Hawthorne Effect Inc.
Uqora, Inc.

Terminated

Uqora Supplements in Women With UTIs

Urinary Tract Infections

United States

3

Subscribe